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The injustice of unfit clinical practice guidelines in 
low-resource realities
Nanna Maaløe, Anna Marie Rønne Ørtved, Jane Brandt Sørensen, Brenda Sequeira Dmello, Thomas van den Akker, Monica Lauridsen Kujabi, 
Hussein Kidanto, Tarek Meguid, Ib Christian Bygbjerg, Jos van Roosmalen, Dan Wolf Meyrowitsch, Natasha Housseine
To end the international crisis of preventable deaths in low-income and middle-income countries, evidence-informed 
and cost-efficient health care is urgently needed, and contextualised clinical practice guidelines are pivotal. However, 
as exposed by indirect consequences of poorly adapted COVID-19 guidelines, fundamental gaps continue to be 
reported between international recommendations and realistic best practice. To address this long-standing injustice 
of leaving health providers without useful guidance, we draw on examples from maternal health and the COVID-19 
pandemic. We propose a framework for how global guideline developers can more effectively stratify recommendations 
for low-resource settings and account for predictable contextual barriers of implementation (eg, human resources) as 
well as gains and losses (eg, cost-efficiency). Such development of more realistic clinical practice guidelines at the 
global level will pave the way for simpler and achievable adaptation at local levels. We also urge the development and 
adaptation of high-quality clinical practice guidelines at national and subnational levels in low-income and middle-
income countries through co-creation with end-users, and we encourage global sharing of these experiences.
Introduction
“The women are in pain, some look frightened and many 
are calling for my attention. It is a typical night duty in the 
maternity ward. Eighteen women are admitted in the 
congested labour room, two in each bed. A young nurse 
and I are the only staff in the room. I see a head crowning 
in bed four and an oxytocin drip next to bed two running 
too fast. The nurse reports that one of the women with 
severe preeclampsia is fitting. It is a long time since any 
woman had assessments of foetal heart rates, and their 
unborn babies may have been crying out for help in 
silence. I am quickly casting a glance on the room’s 
wallpaper of guidelines. They all are there, from the 
Ministry of Health to international aid organizations. 
Fading instructions and illustrations depict the what-if 
scenarios if only I had one woman with one illness at a 
time. I force my gaze back at reality and feel alone” 
(reconstruction of lived experiences of health professionals 
in Tanzanian maternity units, unpublished data).
Each year, more than 295 000 maternal deaths and 
5 million stillbirths and neonatal deaths occur worldwide, 
of which the vast majority of these deaths take place in 
low-income and middle-income countries (LMICs).1,2 
Many of these deaths would be preventable with access to 
quality health care during pregnancy and childbirth, and 
the economic and psychosocial return on investment 
would be massive for families and societies.3 However, 
although the number of facility births have increased, the 
quality of care has not adequately followed suit.
During the past two decades, the development of 
clinical practice guidelines (CPGs) has been a central 
strategy to cost-efficiently improve maternal health 
care in low-resource settings.4–6 Moreover, the rapidly 
expanding number of CPGs have laid the foundations for 
a variety of other interventions. However, as we found in 
a literature search of childbirth CPGs in African hospitals 
(appendix p 4), fundamental gaps between international 
recommendations and realistic best practice continue 
to be reported in low-resource settings, and evaluation 
of the implementation and effectiveness of CPGs is 
largely neglected. Similar discrepancies between CPGs 
and realistic best practice are reported in other fields 
of medicine,7–9 and such discrepancies have also been 
exposed by the interim COVID-19 guidelines (appendix 
p 2).10,11 Within and beyond maternal health, these 
discrepancies cause alarming risks of preventing actual 
use of CPGs, disenfranchising and demoralising health 
providers, draining resources, and, paradoxically, causing 
unintentional harm in clinical practice.12–14 This issue 
raises the question of whose views count in CPG 
development, implementation, and aspiration?15
In this Viewpoint, we address this underexposed yet 
long-standing injustice of leaving health providers 
without useful guidance. We suggest ways forward, and 
we call for action, at global and local levels, to develop 
contextualised, realistic CPGs for health providers 
practising where guidance is most acutely needed.
Whose perspectives count in current CPGs?
When comparing multiple international, high-quality 
maternal health CPGs, important inconsistencies and 
disagreements are seen, even between concurrently 
published so-called high-quality CPGs.16 These incon-
sistencies and disagreements highlight limitations in 
experimental studies and the strong influence of values, 
culture, and professional tradition, even in what are 
considered high-quality CPGs.17 Translating evidence 
into recommendations inevitably requires judgements 
about the balance between benefits and risks, and 
involves combining selective and restricted study 
findings. However, the front-line health providers, who 
are the experts in low-resource clinical practice and the 
pivotal agents of sustainable development, are rarely 
invited to participate in such judgements and tailoring. 
Not only are these clinical experts scarcely represented 
in CPG development, pilot testing among end-users of 
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CPGs and postimplementation evaluation are largely 
neglected.5
Multilateral health agencies appear to take for 
granted that their CPGs will be adequately adapted to 
local contexts regionally, nationally, or subnationally.4 
However, it is generally acknowledged that few LMICs 
are equipped with the necessary human, technical, 
and financial resources to carry out such adaptations, 
including time, access to evidence, knowledge and 
training on synthesising and applying evidence, and 
coordination of the different stakeholders.9,12,18,19 
Therefore, international recommendations are typically 
endorsed nationally after varying degrees of suboptimal 
adaptation by a panel of experts, or even (inappropriately) 
directly adopted. Front-line health providers are often not 
invited to influence these processes of GPG development 
or adaptation nationally, but they are asked to use CPGs 
that are dangerously incomplete, irrelevant, impractical, 
or outdated.12,18,19 Some of the CPGs are predictably 
unachievable, which can catalyse stress and resistance to 
change among already strained health providers, instead 
of achieving goals and increasing commitment and job 
satisfaction.14 For instance, spending 10 min half-hourly 
with each labouring woman counting fetal heart rate 
and contractions is mathematically impossible when 
simultaneously caring for three or more women.19 Other 
recommendations might appear achievable but are 
resource consuming and harmful. For instance, risk 
ratios of vaginal breech births versus caesarean sections 
differ between high-resource and low-resource settings, 
given that the surgical safety that can be achieved in 
high-income countries (HICs) can rarely be met when 
resources are scarce.20 Likewise, although the use of 
oxytocin augmentation is recommended in LMICs as it 
is in HICs, higher risks of adverse perinatal outcomes 
are predictable in settings without one-to-one care and 
poor surveillance, no electronic drip counts, and delayed 
access to emergency surgery and blood transfusion.19 Yet 
other recommendations might unintentionally over-
influence practice, leaving other essential care further 
under-resourced. As elaborated in the appendix (p 2), 
WHO’s non-integrated, vertical COVID-19 guidelines is 
an example of this. For instance, as COVID-19 symptoms 
mimic obstetric emergencies, triaging women with 
concomitant obstetric complications might be delayed if 
vertical COVID-19 responses overinfluence care.10
Astonishingly, augmentation of the technical bar for 
evidence synthesis in CPG development, which has 
occurred over the past two decades, has not been matched 
by a strengthened focus on pilot testing and post-
implementation evaluation. This finding stands in 
contrast to CPG research in HICs, and implementation 
science in general, in which co-creation, pilot testing, 
and postimplementation evalua tion are acknowledged 
to be central means for success.13,21,22 Notably, while 
medications have to pass through multiple phases of 
trials before approval, as well as post-approval 
monitoring, CPGs (eg, for drug dosages and indications) 
are often disseminated without any pilot testing or 
postimplemen tation testing of effects, and side-effects. In 
the original AGREE appraisal tool, the go-to tool to assess 
methodological rigour in CPG development, pilot testing 
was included as an integrated part of stakeholder 
involvement. In the second version, however, pilot testing 
was reduced to one of many additional suggestions 
for what might be included in the methodological 
assessment.6 Strengthening evidence synthesis of CPGs 
could even, paradoxically, have counteracted the influence 
of end-users, by predominantly focusing on evidence 
generated through experimental study designs, which 
control for the essential contextual factors.5,23
Making end-users’ perspectives count
At national and sub-national levels
From the scarce literature regarding co-created CPGs in 
low-resource settings (appendix p 4),7,8,16 we present two 
examples from sub-Saharan Africa in this Viewpoint. 
Both examples provide elaborate descriptions of CPG 
development and evaluation, and they expose potentially 
essential factors for effectiveness in such processes.9,19
One example is a Kenyan approach to co-creation of 
paediatric CPGs, which was carried out at national level 
and applied top-down.9 The other example is the Zanzibar 
initiative for obstetric CPGs (the PartoMa project), which 
was based on a bottom-up approach, in which CPGs 
were co-created with health providers in one hospital and 
later scaled up.19 There are many similarities between 
these programmes, which both followed overarching 
principles of “problem-driven iterative adaptation”.13 
First, locally identified problems led the structured 
CPG development process, and CPGs were updated in 
response to emerging local issues and other feedback 
from end-users, as well as emerging external evidence. 
Second, to ensure legitimate, relevant and supportable 
recommendations, and to avoid CPG duplication and 
contradictions, the co-creators included clinicians with 
and without speciality training (ie, the end-users, while 
taking their limited time into account) as well as other 
stakeholders (eg, community members and policy 
makers). Third, the end product was a short booklet of 
integrated, basic routine and emergency management, 
presented as infographics for busy health providers 
without specialty training. Finally, the CPGs were 
widely disseminated at knowledge and skills courses, 
which included trainers who were directly involved in the 
CPG co-creation (once in Kenya and recurring in 
Zanzibar). The Kenyan CPGs have been integrated into 
undergraduate and postgraduate paediatric training, and 
CPGs from the PartoMa project are currently being 
modified and tested in Dar es Salaam, Tanzania. Both 
programmes have reported concurrent improvements in 
clinical practice. Also, they report enthusiasm among 
CPG co-creators and users, including greater appreciation 
of the value and limitations of evidence and an emerging 
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sense of ownership. An added benefit of CPG co-
creations with end-users is that the need for better 
evidence to inform CPG development processes in low-
resource settings is disclosed.9,19,23
The Kenyan approach was used to develop CPGs 
de novo, whereas the primary focus of the PartoMa 
project was on adapting internationally-derived CPGs.9,19 
Although de-novo synthesis might strengthen a sense 
that the local team’s role “is not just to endorse global 
recommendations”,9 high-quality contextualisation and 
adaptation of international CPGs might have greater 
potential to make the best use of scarce resources.7 
However, CPG adaptation processes in low-resource 
settings remain unrealistically time-consuming and 
resource-draining because of the discrepancies between 
externally derived CPGs and realistic best practice, and 
due to missing information in the externally derived 
CPGs (eg, on what human resources are needed to follow 
recommendations, on cost-effectiveness, and on how the 
values and preferences of the targeted population were 
evaluated). High-quality CPGs that have already been 
developed in comparable low-resource settings would 
ease adaptation to new locations, and such development 
experiences and products should be routinely shared 
internationally.7,12,18,19,24 Moreover, as self-reflected by 
WHO’s Guidelines Review Committee, tools for CPG 
adaptation, implementation, and updating should be 
planned from the beginning of each CPG development 
and not merely “treated as afterthoughts”.5
At the global level
It should be achievable to develop useful and effective 
CPGs at global level that are closer to realities in LMICs, 
thereby paving the way for simpler adaptation. Although 
there are some promising examples of more specific 
CPGs with lesser need for adaptation (eg, for neonatal 
resuscitation),25 the effectiveness of directly adopted 
broader, integrated CPGs for complex clinical manage-
ment is questionable (eg, intrapartum guidance to avoid 
the underlying neonatal asphyxia; appendix p 4). To 
take better account of linkages between interventions 
and contexts in CPG development, WHO launched an 
initiative in 2016 to broaden their evidence synthesis 
and better incorporate qualitative data and complex 
intervention research. This initiative resulted in the 
WHO-INTEGRATE framework, which encourages a 
structured process of reflections during CPG develop-
ment (ie, integrating health benefits and harms, human 
rights and sociocultural acceptability, financial and 
economic considerations, health equity, equality, and non-
discrimination, societal implications and feasibility, and 
health systems considerations).23 This framework can 
hopefully assist in stratifying CPGs to different contexts 
already at global level, so that the CPGs are in accordance 
with, for example, health provider-to-patient ratios. 
Notably, this approach would follow WHO’s long-standing 
aspiration to develop “conditional recommendations”4 
when interventions are suitable for some locations only, of 
which the WHO’s essential drugs list is a successful 
example.24
However, actual use of the WHO-INTEGRATE 
approach might be challenged by the often scarce 
number of complex implementation studies with 
detailed descriptions of context.21 Hence, interpreting 
and combining the findings of trials with restricted 
real-world applicability is still a central part of CPG 
development. Inspired by a model for large-scale CPG 
development in HICs, we propose that context strati-
fication based on pre-decided criteria, as depicted by the 
WHO-INTEGRATE framework (eg, provider-to-patients 
ratios), is viewed only as the first of three steps at 
global level, after which iterative cycles of adaptation, 
implementation, and evaluation are implemented 
nationally and sub-nationally (appendix p 3).22 The 
second step at global level should require field visits in 
different settings, to identify less predictable barriers to 
implementation and effectiveness, and to identify 
possible side-effects. WHO’s Better Outcomes in Labour 
Difficulty (BOLD) project provides an encouraging 
example of such negotiation of best possible standards 
among end-users and target populations in selected 
Ugandan and Nigerian health facilities.26 Field visits 
should also include assessment of risks for contradictive 
recom mendations, counterproductive guide lines over-
load, or vertical guidance over-influencing care. Finally, 
merely distribu ting CPGs is not sufficient to reach high-
quality clinical decision making. Even easily adaptable 
recommendations enter a local process of becoming 
politically and institutionally embedded, and the third 
step at global level concerns supporting this process. 
This third step might, for instance, include development 
of realistic performance measures for evaluation of 
CPG use and effects, CPG-related undergraduate and 
postgraduate training components, and user-friendly 
CPG algorithms and manuals. Notably, the brief info-
graphics in the aforementioned Kenyan and PartoMa 
CPGs follow the evidence of decision science on the 
centrality of heuristics in decision making. Also within 
clinical practice in HICs, such fast and frugal clinical 
decision support tools are called for, which should not 
overwhelm health providers by their sheer volume of 
recom mendations, but should stimulate dialogue with 
colleagues and patients (eg, by presenting pros and cons 
lists) and assist with multiple simultaneous actions in 
complex realities.27 Notably, particularly in resource-
scarce settings with suboptimal undergraduate and 
postgraduate training, CPGs could be a central means to 
stimulate creativity and flexibility of the mind, which is 
crucial to provide best possible care for the many with 
the limited resources available.
Digital health, including artificial intelligence, might 
become central in designing cost-efficient models for 
CPGs targeting LMICs by, for instance: (1) assisting in 
CPG development, such as systematic reviews, expert 
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consensus, Delphi approaches, and data mining; 
(2) developing CPGs with embedded algorithms, which 
cost-efficiently stratify recommendations to resource 
levels and other contextual features, and allow for the 
possibility of rapid modifications; (3) strengthening CPG 
use through digital decision support tools that reduce 
workloads; and (4) embedding feedback loops to facilitate 
rapid learning from end-users.28 However, in current 
CPG-based digital decision-support tools for LMICs, 
pre-made so-called best-practice eHealth solutions 
often appear non-adjustably based on generic CPGs. 
For instance, an evaluation in Kenya of an electronic 
partograph to assist in timely surveillance during birth 
raised concerns of how this potentially effective 
intervention could be implemented at busy sites where 
only a small number of health providers are available. 
The electronic partograph releases audible reminders 
when clinical measurements are due, but the intervention 
developers and evaluators have not assessed contextual 
feasibility of WHO’s recommendations for labour 
surveillance, which were adopted directly into the 
intervention.29
Ethical considerations
Pragmatic CPG development might be criticised for 
promoting suboptimal practices, inefficiently replicating 
previous interventions, failing to meet global standards, 
or prolonging the unacceptable status quo.13 We do 
acknowledge ethical dilemmas in producing acceptable 
guidance for unacceptable realities with the human 
resources crisis at its centre. Yet, acceptable guidance is 
a moral duty to deal with realities that must not be 
accepted in the long run, but that do currently exist. 
Settings with scarce resources should thoroughly 
consider efficiency and equity of resource use, and 
global health care should not imply identical health 
care: “this is the balance between globalizing evidence 
and localizing decisions that will improve health care 
worldwide”.30 In line with the Paris Declaration on Aid 
Effectiveness and the Accra Agenda for Action, this 
redirection of accountability at global, national, and 
subnational levels enables health providers in resource-
constrained facilities to improve control and influence 
how problems and solutions are outlined at the global 
level.15 Overworked birth attendants require access 
to professional development and supervision, for which 
realistic CPGs are fundamental.31 Such aspirations for 
respectful work conditions (Sustainable Development 
Goals 3c and 8·8) are pivotal for providing best possible 
safe and respectful care and strengthening the account-
ability of health systems (Sustainable Development 
Goals 3.1, 3.2, and 5.1).
A call for action at global and local levels
In the era of personalised medicine in HICs, 
context-stratified, realistic CPGs for LMICs are long 
overdue. Such CPGs should be formulated to facilitate 
implementation, and with embedded feedback loops 
to stimulate rapid experiential learning throughout 
development and implementation. Funding constraints 
can be argued as a central challenge that influences both 
priority setting and quality of CPG development.5 
Meanwhile, the current isomorphic mimicry of nations 
adopting poorly fitting CPGs causes capability traps, 
where scarce resources are effectively lost in developing 
and implementing ineffective CPGs.13 The case is clear: 
the need for evidence-informed and cost-efficient health 
care without wastage is urgent in LMICs, within and 
beyond maternal health, and translating evidence into 
practice is most successful when contextual differences 
and needs are factored into the decision-making 
process.16,23,30 We believe that development and adaptation 
of high-quality, contextualised, realistic CPGs will assist 
health providers in saving lives rather than causing 
immobility by a desire for perfection.
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